Evaluation of the pertussis surveillance system: progress and challenges
Evaluación del sistema de vigilancia de la tos ferina: avances y desafíosMain Article Content
Introduction: Whooping cough is a vaccine-preventable disease that primarily affects unvaccinated infants, representing a public health challenge that requires effective epidemiological surveillance. Objective: To evaluate the whooping cough surveillance system in Alto Paraná, Paraguay, analyzing its epidemiological behavior between 2019 and 2023. Materials and Method: A quantitative, descriptive, and cross-sectional study was conducted in two phases: the first analyzed reported cases using the Expanded Program on Immunization database; the second evaluated qualitative attributes of the system (simplicity, acceptability, and usefulness) through surveys of 110 physicians. Results: A total of 66 suspected cases were reported, with a median age of 0.5 years and a predominance in children under one year of age (68.2%); 67% were hospitalized, all had cough, and 50% had fever. The incidence was 0.5 cases per 100,000 inhabitants, higher than the national average, with vaccination coverage <80%. Ninety-two percent of physicians perceived the system as fair; usefulness was the most highly valued attribute (79%). Conclusions: The system requires strengthening active surveillance, operational simplification, and improved vaccination coverage to optimize early detection and outbreak control.
Introducción: La tos ferina es una enfermedad inmunoprevenible que afecta principalmente a lactantes no vacunados, representando un desafío para la salud pública que exige vigilancia epidemiológica efectiva. Objetivo: Evaluar el sistema de vigilancia de la tos ferina en Alto Paraná, Paraguay, analizando su comportamiento epidemiológico entre 2019 y 2023. Materiales y Método: Se realizó un estudio cuantitativo, descriptivo y transversal en dos fases: la primera analizó los casos notificados utilizando la base de datos del Programa Ampliado de Inmunizaciones; la segunda evaluó atributos cualitativos del sistema (simplicidad, aceptabilidad y utilidad) mediante encuestas a 110 médicos. Resultados: Se notificaron 66 casos sospechosos, con mediana de edad de 0,5 años y predominio en menores de un año (68,2%); 67% fueron hospitalizados, todos presentaron tos y 50% fiebre. La incidencia fue de 0,5 casos por 100.000 habitantes, superior a la nacional, con cobertura vacunal <80%. El 92% de los médicos percibió el sistema como regular; la utilidad fue el atributo mejor valorado (79%). Conclusiones: El sistema requiere fortalecimiento en vigilancia activa, simplificación operativa y mejora de coberturas vacunales para optimizar la detección temprana y el control de brotes.
Downloads
Article Details
Organización Mundial de la Salud. Tos ferina. Ginebra: OMS; 2023. https://www.who.int/news-room/fact-sheets/detail/pertussis
Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Clinical Features. Atlanta: CDC; 2023 [citado 18 mar 2024]. https://www.cdc.gov/pertussis/clinical/features.html
Organización Panamericana de la Salud. Guía para la vigilancia de la tos ferina (pertussis) en las Américas. Washington, D.C.: OPS; 2022. https://iris.paho.org/handle/10665.2/55847
Yeung H, Duclos P, Nelson A, Hutubessy C. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974-980. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30390-0/fulltext
Zouari A, Smaoui H, Brun D, Njamkepo E, Sghaier S, Felix R, et al. Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study. Diagn Microbiol Infect Dis. 2012;72(4):303-317. https://pubmed.ncbi.nlm.nih.gov/22277919/
van der Zee A, Vernooij S, Peeters M, van Embden J, Mooi F. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology. 1996;142(12):3479-3485. https://www.microbiologyresearch.org/content/journal/micro/10.1099/13500872-142-12-3479
Plotkin, Stanley A., et al. Plotkin’s Vaccines. Seventh edition, Elsevier, 2018, https://doi.org/10.1016/C2013-0-18914-3.
Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012-1019. https://www.nejm.org/doi/full/10.1056/NEJMoa1200850
Sheridan S, Frith K, Snelling T, Grimwood K, McIntyre P, Lambert S. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines. 2014;13(9):1081-1106. https://www.tandfonline.com/doi/abs/10.1586/14760584.2014.944167
Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521-1528. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60686-3/fulltext
Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis. 2015;60(3):333-337. https://academic.oup.com/cid/article/60/3/333/415644
Healy C, Rench M, Wootton S, Castagnini L. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015;34(1):22-26. https://journals.lww.com/pidj/Abstract/2015/01000/Evaluation_of_the_Impact_of_a_Pertussis_Cocooning.6.aspx
Ministerio de Salud Pública y Bienestar Social, Paraguay. Manual de vigilancia epidemiológica de enfermedades transmisibles. 4ª ed. Asunción: MSPBS; 2021. https://www.mspbs.gov.py/dependencias/vigepi/adjunto/5c2a52-ManualdeVigilanciaEpidemiolgica2021.pdf
World Health Organization. Vaccine-preventable diseases surveillance standards: pertussis. Geneva: WHO; 2018. https://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_16_Pertussis_R2.pdf
German R, Lee L, Horan J, Milstein R, Pertowski C, Waller M. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1-35. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm
Organización Panamericana de la Salud. Estado de la inmunización en las Américas: informe anual 2022. Washington, D.C.: OPS; 2023. https://iris.paho.org/handle/10665.2/57456
Ministerio de Salud Pública y Bienestar Social, Paraguay. Programa Ampliado de Inmunizaciones: manual normativo. 6ª ed. Asunción: MSPBS; 2022. https://www.mspbs.gov.py/dependencias/pai/adjunto/164a1d-ManualPAI2022Final.pdf
Dirección General de Estadística, Encuestas y Censos. Proyección de la población por sexo y edad, según distrito. 2000-2025. Fernando de la Mora: DGEEC; 2020. https://www.dgeec.gov.py/Publicaciones/Biblioteca/proyeccion%20nacional/Proyeccion%20Distrital.pdf
Leguizamón M, Aquino R, Báez C, Giménez G, Ortiz Z. Coberturas de vacunación en Paraguay: análisis de la Encuesta de Demografía y Salud 2016. Rev Panam Salud Publica. 2020;44:e1. https://iris.paho.org/handle/10665.2/51614
Unicef Paraguay. Análisis de situación de la inmunización en Paraguay. Asunción: Unicef; 2021. https://www.unicef.org/paraguay/informes/analisis-de-situacion-de-la-inmunizacion-en-paraguay
Ministerio de Salud de Brasil. Boletim Epidemiológico: Coqueluche - Brasil 2019-2023. Brasília: MS; 2024. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos
Ministerio de Salud de Argentina. Boletín Integrado de Vigilancia. Buenos Aires: MS; 2023. https://www.argentina.gob.ar/salud/epidemiologia/boletines
Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis. 2013;13:151. https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-151
Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;161(6):1091-1096. https://www.jpeds.com/article/S0022-3476(12)00793-2/fulltext
Secretaria de Vigilância em Saúde, Brasil. Situação epidemiológica da coqueluche no Brasil: 2010 a 2019. Bol Epidemiol. 2020;51(35):11-18. https://antigo.saude.gov.br/images/pdf/2020/setembro/09/Boletim-epidemiologico-SVS-35-aa.pdf
Ministerio de Salud de Argentina. Análisis de situación de salud: tos convulsa en Argentina 2015-2019. Buenos Aires: MS; 2020. https://bancos.salud.gob.ar/recurso/analisis-de-situacion-de-salud-tos-convulsa-en-argentina-2015-2019
Schwartz K, Kwong J, Deeks S, Campitelli M, Jamieson F, Marchand-Austin A, et al. Effectiveness of pertussis vaccination and duration of immunity. CMAJ. 2016;188(16):E399-E406. https://www.cmaj.ca/content/188/16/E399
Bisgard K, Pascual F, Ehresmann K, Miller C, Cianfrini C, Jennings C, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23(11):985-989. https://journals.lww.com/pidj/Abstract/2004/11000/Infant_pertussis_who_was_the_source.1.aspx
Vilajeliu A, García-Basteiro A, Valencia S, Bayas J. Pertussis in pregnant women and newborns: a systematic review of the global epidemiology. Expert Rev Vaccines. 2015;14(9):1279-1294. https://www.tandfonline.com/doi/abs/10.1586/14760584.2015.1057572
Carbonetti N. Pertussis toxin and adenylyl cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol. 2010;5(3):455-469. https://www.futuremedicine.com/doi/abs/10.2217/fmb.09.133
Fine E, Clarkson J. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet. 1982;1(8273):666-669. https://www.thelancet.com/journals/lancet/article/PII0140-6736(82)92214-4/fulltext
Hethcote H. An age-structured model for pertussis transmission. Math Biosci. 1997;145(2):89-136. https://www.sciencedirect.com/science/article/pii/S0025556497000144
Riffelmann M, Wirsing von König CH, Caro V, Guiso N. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43(10):4925-4929. https://journals.asm.org/doi/10.1128/JCM.43.10.4925-4929.2005
Mattoo S, Cherry J. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326-382. https://journals.asm.org/doi/10.1128/CMR.18.2.326-382.2005
Jajosky R, Groseclose S. Evaluation of reporting timeliness of public health surveillance systems for infectious diseases. BMC Public Health. 2004;4:29. https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-4-29
M’ikanatha N, Lynfield R, Van Beneden C, de Valk H, editores. Infectious disease surveillance. 2ª ed. Oxford: Blackwell Publishing; 2013. https://www.wiley.com/en-us/Infectious+Disease+Surveillance%2C+2nd+Edition-p-9780470654675